vs
Side-by-side financial comparison of EXELIXIS, INC. (EXEL) and CHART INDUSTRIES INC (GTLS). Click either name above to swap in a different company.
CHART INDUSTRIES INC is the larger business by last-quarter revenue ($1.1B vs $598.7M, roughly 1.8× EXELIXIS, INC.). EXELIXIS, INC. runs the higher net margin — 40.8% vs 5.0%, a 35.9% gap on every dollar of revenue. On growth, EXELIXIS, INC. posted the faster year-over-year revenue change (5.6% vs -2.5%). EXELIXIS, INC. produced more free cash flow last quarter ($332.4M vs $66.2M). Over the past eight quarters, EXELIXIS, INC.'s revenue compounded faster (18.7% CAGR vs 6.6%).
Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration (FDA) for medullary thyroid cancer with clinical activity in several other types of metastatic cancer.
Oricon Inc. , established in 1999, is the holding company at the head of a Japanese corporate group that supplies statistics and information on music and the music industry in Japan and Western music. It started as Original Confidence Inc. , which was founded by Sōkō Koike in November 1967 and became known for its music charts. Oricon Inc. was originally set up as a subsidiary of Original Confidence and took over the latter's Oricon record charts in April 2002.
EXEL vs GTLS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $598.7M | $1.1B |
| Net Profit | $244.5M | $53.6M |
| Gross Margin | 95.6% | 33.3% |
| Operating Margin | 39.3% | 11.6% |
| Net Margin | 40.8% | 5.0% |
| Revenue YoY | 5.6% | -2.5% |
| Net Profit YoY | 74.8% | -32.7% |
| EPS (diluted) | $0.89 | $1.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $598.7M | — | ||
| Q4 25 | $597.8M | $1.1B | ||
| Q3 25 | $568.3M | $1.1B | ||
| Q2 25 | $555.4M | $1.1B | ||
| Q1 25 | $566.8M | $1.0B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | $539.5M | $1.1B | ||
| Q2 24 | $637.2M | $1.0B |
| Q1 26 | $244.5M | — | ||
| Q4 25 | $193.6M | $53.6M | ||
| Q3 25 | $184.8M | $-138.5M | ||
| Q2 25 | $159.6M | $76.1M | ||
| Q1 25 | $139.9M | $49.5M | ||
| Q4 24 | — | $79.6M | ||
| Q3 24 | $118.0M | $69.0M | ||
| Q2 24 | $226.1M | $58.6M |
| Q1 26 | 95.6% | — | ||
| Q4 25 | 96.9% | 33.3% | ||
| Q3 25 | 96.6% | 34.1% | ||
| Q2 25 | 96.5% | 33.6% | ||
| Q1 25 | 96.5% | 33.9% | ||
| Q4 24 | — | 33.6% | ||
| Q3 24 | 96.8% | 34.1% | ||
| Q2 24 | 97.2% | 33.8% |
| Q1 26 | 39.3% | — | ||
| Q4 25 | 39.6% | 11.6% | ||
| Q3 25 | 37.6% | -8.0% | ||
| Q2 25 | 33.6% | 15.7% | ||
| Q1 25 | 28.8% | 15.2% | ||
| Q4 24 | — | 17.0% | ||
| Q3 24 | 25.2% | 16.8% | ||
| Q2 24 | 43.3% | 16.1% |
| Q1 26 | 40.8% | — | ||
| Q4 25 | 32.4% | 5.0% | ||
| Q3 25 | 32.5% | -12.6% | ||
| Q2 25 | 28.7% | 7.0% | ||
| Q1 25 | 24.7% | 4.9% | ||
| Q4 24 | — | 7.2% | ||
| Q3 24 | 21.9% | 6.5% | ||
| Q2 24 | 35.5% | 5.6% |
| Q1 26 | $0.89 | — | ||
| Q4 25 | $0.69 | $1.06 | ||
| Q3 25 | $0.65 | $-3.23 | ||
| Q2 25 | $0.55 | $1.53 | ||
| Q1 25 | $0.47 | $0.94 | ||
| Q4 24 | — | $1.57 | ||
| Q3 24 | $0.40 | $1.33 | ||
| Q2 24 | $0.77 | $1.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.1B | $366.0M |
| Total DebtLower is stronger | — | $3.7B |
| Stockholders' EquityBook value | $2.2B | $3.2B |
| Total Assets | $2.8B | $9.8B |
| Debt / EquityLower = less leverage | — | 1.13× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $1.1B | — | ||
| Q4 25 | $988.5M | $366.0M | ||
| Q3 25 | $791.1M | $399.2M | ||
| Q2 25 | $1.0B | $342.3M | ||
| Q1 25 | $1.1B | $296.2M | ||
| Q4 24 | — | $308.6M | ||
| Q3 24 | $1.2B | $310.2M | ||
| Q2 24 | $1.0B | $247.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | $3.7B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $3.8B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $2.2B | — | ||
| Q4 25 | $2.2B | $3.2B | ||
| Q3 25 | $2.0B | $3.2B | ||
| Q2 25 | $2.1B | $3.4B | ||
| Q1 25 | $2.2B | $3.0B | ||
| Q4 24 | — | $2.8B | ||
| Q3 24 | $2.3B | $3.0B | ||
| Q2 24 | $2.1B | $2.7B |
| Q1 26 | $2.8B | — | ||
| Q4 25 | $2.8B | $9.8B | ||
| Q3 25 | $2.7B | $9.8B | ||
| Q2 25 | $2.8B | $9.7B | ||
| Q1 25 | $2.9B | $9.3B | ||
| Q4 24 | — | $9.1B | ||
| Q3 24 | $3.0B | $9.5B | ||
| Q2 24 | $2.8B | $9.3B |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.13× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.33× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $333.5M | $88.8M |
| Free Cash FlowOCF − Capex | $332.4M | $66.2M |
| FCF MarginFCF / Revenue | 55.5% | 6.1% |
| Capex IntensityCapex / Revenue | 0.2% | 2.1% |
| Cash ConversionOCF / Net Profit | 1.36× | 1.66× |
| TTM Free Cash FlowTrailing 4 quarters | $875.8M | $202.8M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $333.5M | — | ||
| Q4 25 | $290.3M | $88.8M | ||
| Q3 25 | $49.0M | $118.0M | ||
| Q2 25 | $211.4M | $145.9M | ||
| Q1 25 | $240.3M | $-60.0M | ||
| Q4 24 | — | $281.4M | ||
| Q3 24 | $271.3M | $200.6M | ||
| Q2 24 | $119.5M | $116.1M |
| Q1 26 | $332.4M | — | ||
| Q4 25 | $288.8M | $66.2M | ||
| Q3 25 | $46.2M | $94.7M | ||
| Q2 25 | $208.5M | $122.0M | ||
| Q1 25 | $236.3M | $-80.1M | ||
| Q4 24 | — | $260.9M | ||
| Q3 24 | $263.1M | $174.5M | ||
| Q2 24 | $113.0M | $88.0M |
| Q1 26 | 55.5% | — | ||
| Q4 25 | 48.3% | 6.1% | ||
| Q3 25 | 8.1% | 8.6% | ||
| Q2 25 | 37.5% | 11.3% | ||
| Q1 25 | 41.7% | -8.0% | ||
| Q4 24 | — | 23.6% | ||
| Q3 24 | 48.8% | 16.4% | ||
| Q2 24 | 17.7% | 8.5% |
| Q1 26 | 0.2% | — | ||
| Q4 25 | 0.2% | 2.1% | ||
| Q3 25 | 0.5% | 2.1% | ||
| Q2 25 | 0.5% | 2.2% | ||
| Q1 25 | 0.7% | 2.0% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | 1.5% | 2.5% | ||
| Q2 24 | 1.0% | 2.7% |
| Q1 26 | 1.36× | — | ||
| Q4 25 | 1.50× | 1.66× | ||
| Q3 25 | 0.27× | — | ||
| Q2 25 | 1.32× | 1.92× | ||
| Q1 25 | 1.72× | -1.21× | ||
| Q4 24 | — | 3.54× | ||
| Q3 24 | 2.30× | 2.91× | ||
| Q2 24 | 0.53× | 1.98× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EXEL
| Cabometyx | $544.7M | 91% |
| Collaboration | $52.1M | 9% |
| Collaborative Arrangementwith Takeda | $5.9M | 1% |
| Cometriq | $1.8M | 0% |
GTLS
| Repair Service And Leasing Segment | $330.4M | 31% |
| Heat Transfer Systems Segment | $325.8M | 30% |
| Specialty Products Segment | $259.5M | 24% |
| Transferred Over Time | $94.4M | 9% |
| Transferred At Point In Time | $69.5M | 6% |
